BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Quality First International Release: New ASEAN Draft Medical Device Directive: Will It Create the Hoped for Economic Boost for the Region?


5/23/2013 9:52:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

London, 23 May 2013 -- Haroon Atchia – CEO of the London-based medical device regulatory consultancy Quality First International – has written a critical examination of the draft Association of Southeast Asian Nations (ASEAN) Medical Device Directive (MDD).

The document entitled “Examination of the ASEAN draft Medical Device Directive” explores the proposed new directive and examines questions related to device registration, market placement, controls and responsibilities. In particular, Atchia compares the scope and content of the draft ASEAN MDD with the requirements of the European MDD to help readers who are not familiar with the current ASEAN regulations to understand the draft ASEAN MDD.

The draft ASEAN MDD is expected to produce significant advantages to the economy of the region. It is also anticipated that, over time, the ASEAN MDD will yield the same benefits (as well as drawbacks) as the European MDD. However, the examination identifies considerable improvements needed in numerous fundamental areas before it becomes a workable scheme.

A 3 page summary of the ASEAN MDD is available for FREE download from: www.qualityfirstint.com. The summary will also be available in French and German shortly.

The full, detailed report of approx. 150 pages will be published soon.

About Quality First International

Quality First International (QFI) is a London-based medical devices consulting company specialising in solving its clients’ regulatory, technical and compliance challenges to enable medical devices to enter the global marketplace. Quality First International provides regulatory advice, quality assurance and clinical trial services, with particular emphasis on the European, US, Japanese, Australian, Canadian, Mexican and Chinese marketplaces. All submissions made by Quality First International have fulfilled the compliance requirements first time round, consistently. Quality First International’s clients range from start-up companies to multinational organisations, primarily developing a broad range of cutting edge, minimally invasive and cardiovascular products and implants.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES